Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 5/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | CDK9 | P50750 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | HTR1B | P28222 | 2/20 | 0.41 |
| ▸ | EPM2A | O95278 | 1/20 | 0.41 |
| ▸ | PTPRC | P08575 | 1/20 | 0.41 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.41 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.41 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.41 |
| ▸ | GPR183 | P32249 | 1/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | WNT3A | P56704 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28085404 | 0.94 | CYP2A6 (0.50) | CYP2A6DYRK1AIDO1CDK9PIM1 | |
| Acetaldehyde SCHEMBL4860532 | 0.88 | CYP2A6 (0.55) | CYP2A6DYRK1AIDO1CDK9PIM1 | |
| SCHEMBL27741085 | 0.83 | DYRK1A (0.65) | CYP2A6DYRK1ACDK9 | |
| Trifluoromethanesulfonic Acid SCHEMBL28759270 | 0.81 | EPM2A (0.47) | CYP2A6IDO1PIM1HTR1BEPM2A | |
| SCHEMBL15544212 | 0.81 | DYRK1A (0.40) | CYP2A6DYRK1AIDO1HTR1BCTNNB1 | |
| SCHEMBL103816 | 0.81 | CYP2A6 (0.44) | CYP2A6IDO1AHRHTR1BKDM4E | |
| SCHEMBL20180505 | 0.80 | DYRK1A (0.56) | DYRK1AIDO1CDK9MAOA | |
| SCHEMBL9581238 | 0.79 | CYP2A6 (0.42) | CYP2A6IDO1AHRHTR1BKDM4E | |
| SCHEMBL7406922 | 0.77 | DYRK1A (0.46) | DYRK1ACDK9 | |
| SCHEMBL4029853 | 0.77 | MAOA (0.41) | CYP2A6PIM1AHRKDM4ENFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 628 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114573534-B | Preparation method of 5-bromobenzofuranone | 八叶草健康产业研究院(厦门)有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-116120374-A | Phosphine ligand catalyst, preparation method thereof and application thereof in synthesizing p-hydroxyanisole | 万华化学集团股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115477631-A | Synthesis method of compound containing dimethyl enol group | 大理大学 | 2022-12-16 | — | — | CN | claimed |
| CN-114957312-A | Aryl silicon compound of conjugated olefin and preparation method and application thereof | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| CN-114853795-A | Arylboron compound of conjugated olefin and preparation method and application thereof | 南京工业大学 | 2022-08-05 | — | — | CN | claimed |
| CN-114685251-A | Direct cross-coupling reaction method of diaryl sulfoxide and aryl bromide | 南京工业大学 | 2022-07-01 | — | — | CN | claimed |
| CN-113402350-A | Biaryl compound and preparation method and application thereof | 南京工业大学 | 2021-09-17 | — | — | CN | claimed |
| CN-107266413-A | Heterocycle and phenylpropionic acid derivative and its preparation method and application | 上海大学 | 2017-10-20 | — | — | CN | claimed |
| CN-103724304-B | The preparation method of 5-bromobenzofuran | 定陶县友帮化工有限公司 | 2016-08-17 | — | — | CN | claimed |
| US-20260092034-A1 | 7-AZAINDOLE ANALOGS AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING THE SAME | KULEON LLC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260085064-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | KARYOPHARM THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4131456-B1 | ORGANIC LIGHT-EMITTING DEVICE | SFC CO LTD (KR) | 2026-02-18 | — | — | EP | disclosed |
| US-12543493-B2 | Organic light-emitting device | SFC CO., LTD. (KR) | 2026-02-03 | — | — | US | disclosed |
| US-20250388570-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SFC CO., LTD (KR) | 2025-12-25 | — | — | US | disclosed |
| US-4341792-A | ANTIDIABETIC AND CARDIOTONIC AGENTS | PFIZER INC. (US) | 1982-07-27 | — | — | US | disclosed |
| EP-0026593-A1 | Bicyclic keto- and amino- acids, esters and amides and pharmaceutical compositions thereof | Pfizer Limited (GB) | 1981-04-08 | — | — | EP | disclosed |
| US-4024273-A | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity | SMITHKLINE CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3983245-A | CORONARY VASODILATORS | SMITHKLINE CORPORATION (US) | 1976-09-28 | — | — | US | disclosed |
| US-3975537-A | SUBSTITUTED BENZOFURANS | SMITH KLINE (US) | 1976-08-17 | — | — | US | disclosed |
| US-3947470-A | CORONARY VASODILATORS, TREATMENT OF ANGINA PECTORIS | SMITHKLINE CORPORATION (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092034-A1 | 7-AZAINDOLE ANALOGS AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING THE SAME | HTR2C, HTR7, HTR6 | CYP2A6 242/4885DYRK1A 1423/4885IDO1 366/4885 |
| US-12543493-B2 | Organic light-emitting device | CRY1, CRY2, AOC2 | CYP2A6 689/4885DYRK1A 3355/4885IDO1 502/4885 |
| US-20250388570-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | AOC2, TRPC1, VDAC1 | CYP2A6 3007/4885DYRK1A 3865/4885IDO1 1205/4885 |
| US-20260085064-A1 | SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF | BCL6, MALT1, BCL6B | CYP2A6 208/4885DYRK1A 4723/4885IDO1 1416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.